Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling

Liu, 2014, Activated STING in a vascular and pulmonary syndrome, N Engl J Med, 371, 507, 10.1056/NEJMoa1312625 Jeremiah, 2014, Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations, J Clin Invest, 124, 5516, 10.1172/JCI79100 Munoz, 2015, Stimulator of interferon genes-associated vasculopathy with onset in infancy: a mimic of childhood granulomatosis with polyangiitis, JAMA Dermatol, 151, 872, 10.1001/jamadermatol.2015.0251 Omoyinmi, 2015, Stimulator of interferon genes-associated vasculitis of infancy, Arthritis Rheumatol, 67, 808, 10.1002/art.38998 Frémond, 2016, Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in three children, J Allergy Clin Immunol, 138, 1752, 10.1016/j.jaci.2016.07.015 König, 2016, Familial chilblain lupus due to a gain-of-function mutation in STING, Ann Rheum Dis Picard, 2016, Severe pulmonary fibrosis as the first manifestation of interferonopathy (TMEM173 mutation), Chest, 150, e65, 10.1016/j.chest.2016.02.682 Clarke, 2016, Interstitial lung disease caused by STING-associated vasculopathy with onset in infancy, Am J Respir Crit Care Med, 194, 639, 10.1164/rccm.201510-2102LE Crow, 2011, Type I interferonopathies: a novel set of inborn errors of immunity, Ann N Y Acad Sci, 1238, 91, 10.1111/j.1749-6632.2011.06220.x Crow, 2014, STING-associated vasculopathy with onset in infancy–a new interferonopathy, N Engl J Med, 371, 568, 10.1056/NEJMe1407246 Ishikawa, 2008, STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling, Nature, 455, 674, 10.1038/nature07317 Burdette, 2011, STING is a direct innate immune sensor of cyclic di-GMP, Nature, 478, 515, 10.1038/nature10429 Barber, 2015, STING: infection, inflammation and cancer, Nat Rev Immunol, 15, 760, 10.1038/nri3921 Zhang, 2013, Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING, Mol Cell, 51, 226, 10.1016/j.molcel.2013.05.022 Dobbs, 2015, STING activation by translocation from the ER is associated with infection and autoinflammatory disease, Cell Host Microbe, 18, 157, 10.1016/j.chom.2015.07.001 Liu, 2015, Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation, Science, 347, aaa2630, 10.1126/science.aaa2630 Lek, 2016, Analysis of protein-coding genetic variation in 60,706 humans, Nature, 536, 285, 10.1038/nature19057 Gentili, 2015, Transmission of innate immune signaling by packaging of cGAMP in viral particles, Science, 349, 1232, 10.1126/science.aab3628 Yi, 2013, Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides, PLoS One, 8, e77846, 10.1371/journal.pone.0077846 Katoh, 2013, MAFFT multiple sequence alignment software version 7: improvements in performance and usability, Mol Biol Evol, 30, 772, 10.1093/molbev/mst010 Robert, 2014, Deciphering key features in protein structures with the new ENDscript server, Nucleic Acids Res, 42, W320, 10.1093/nar/gku316 Ouyang, 2012, Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding, Immunity, 36, 1073, 10.1016/j.immuni.2012.03.019 Konno, 2013, Cyclic dinucleotides triggerULK1(ATG1) phosphorylation of STING to prevent sustained innate immune signaling, Cell, 155, 688, 10.1016/j.cell.2013.09.049 Holm, 2012, Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING, Nat Immunol, 13, 737, 10.1038/ni.2350 Olagnier, 2012, Breaking the barrier: membrane fusion triggers innate antiviral immunity, Nat Immunol, 13, 713, 10.1038/ni.2373 Holm, 2016, Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses, Nat Commun, 7, 10680, 10.1038/ncomms10680 Tanaka, 2012, STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway, Sci Signal, 5, ra20, 10.1126/scisignal.2002521 Tang, 2015, Single amino acid change in STING leads to constitutive active signaling, PLoS One, 10, e0120090, 10.1371/journal.pone.0120090 Shu, 2012, Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system, Nat Struct Mol Biol, 19, 722, 10.1038/nsmb.2331 Mukai, 2016, Activation of STING requires palmitoylation at the Golgi, Nat Commun, 7, 11932, 10.1038/ncomms11932 Hasan, 2015, Cutting edge: inhibiting TBK1 by compound II ameliorates autoimmune disease in mice, J Immunol, 195, 4573, 10.4049/jimmunol.1500162 Hasan, 2016, Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies, Pharmacol Res, 111, 336, 10.1016/j.phrs.2016.04.008 Shigemoto, 2009, Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes, J Biol Chem, 284, 13348, 10.1074/jbc.M809449200